Folate intake and risk of pancreatic cancer: Pooled analysis of prospective cohort studies

Ying Bao, Dominique S. Michaud, Donna Spiegelman, Demetrius Albanes, Kristin E. Anderson, Leslie Bernstein, Piet A. Van Den Brandt, Dallas R. English, Jo L. Freudenheim, Charles S. Fuchs, Graham G. Giles, Edward Giovannucci, R. Alexandra Goldbohm, Niclas Håkansson, Pamela L. Horn-Ross, Eric J. Jacobs, Cari M. Kitahara, James R. Marshall, Anthony B. Miller, Kim RobienThomas E. Rohan, Arthur Schatzkin, Victoria L. Stevens, Rachael Z. Stolzenberg-Solomon, Jarmo Virtamo, Alicja Wolk, Regina G. Ziegler, Stephanie A. Smith-Warner

Research output: Contribution to journalReview article

29 Scopus citations

Abstract

Background Epidemiological studies evaluating the association between folate intake and risk of pancreatic cancer have produced inconsistent results. The statistical power to examine this association has been limited in previous studies partly because of small sample size and limited range of folate intake in some studies. Methods We analyzed primary data from 14 prospective cohort studies that included 319 716 men and 542 948 women to assess the association between folate intake and risk of pancreatic cancer. Folate intake was assessed through a validated food-frequency questionnaire at baseline in each study. Study-specific relative risks (RRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models and then pooled using a random effects model. All statistical tests were two-sided. Results During 7-20 years of follow-up across studies, 2195 pancreatic cancers were identified. No association was observed between folate intake and risk of pancreatic cancer in men and women (highest vs lowest quintile: dietary folate intake, pooled multivariable RR = 1.06, 95% CI = 0.90 to 1.25, Ptrend = .47; total folate intake [dietary folate and supplemental folic acid], pooled multivariable RR = 0.96, 95% CI = 0.80 to 1.16, Ptrend = .90). No between-study heterogeneity was observed (for dietary folate, Pheterogeneity = .15; for total folate, Pheterogeneity = .22). Conclusion Folate intake was not associated with overall risk of pancreatic cancer in this large pooled analysis.

Original languageEnglish (US)
Pages (from-to)1840-1850
Number of pages11
JournalJournal of the National Cancer Institute
Volume103
Issue number24
DOIs
StatePublished - Dec 21 2010

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Folate intake and risk of pancreatic cancer: Pooled analysis of prospective cohort studies'. Together they form a unique fingerprint.

  • Cite this

    Bao, Y., Michaud, D. S., Spiegelman, D., Albanes, D., Anderson, K. E., Bernstein, L., Van Den Brandt, P. A., English, D. R., Freudenheim, J. L., Fuchs, C. S., Giles, G. G., Giovannucci, E., Goldbohm, R. A., Håkansson, N., Horn-Ross, P. L., Jacobs, E. J., Kitahara, C. M., Marshall, J. R., Miller, A. B., ... Smith-Warner, S. A. (2010). Folate intake and risk of pancreatic cancer: Pooled analysis of prospective cohort studies. Journal of the National Cancer Institute, 103(24), 1840-1850. https://doi.org/10.1093/jnci/djr431